PT  - JOURNAL ARTICLE
AU  - Rodolfo Jaffé
AU  - Mabel Ortiz
AU  - Klaus Jaffé
TI  - Globalized low-income countries may experience higher COVID-19 mortality rates
AID  - 10.1101/2020.03.31.20049122
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.31.20049122
4099  - http://medrxiv.org/content/early/2020/04/03/2020.03.31.20049122.short
4100  - http://medrxiv.org/content/early/2020/04/03/2020.03.31.20049122.full
AB  - Understanding the factors underpinning COVID-19 infection and mortality rates is essential in order to implement actions that help mitigate the current pandemic. Here we evaluate how a suit of 15 climatic and socio-economic variables influence COVID-19 exponential growth-phase infection and mortality rates across 36 countries. We found that imports of goods and services, international tourism and the number of published scientific papers are good predictors of COVID-19 infection rates, indicating that more globalized countries may have experienced multiple and recurrent introductions of the virus. However, high-income countries showed lower mortality rates, suggesting that the consequences of the current pandemic will be worse for globalized low-income countries. International aid agencies could use this information to help mitigate the consequences of the current pandemic in the most vulnerable countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding was provided by Instituto Tecnológico Vale, National Council for Scientific and Technological Development (CNPq) grants 301616/2017-5 (RJ) and 203440/2019-6 (RJ), and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) grant 88882.347930/2019-01 (MPO-V).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were retrieved from open-access repositories and links are provided in the text. https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide https://gist.github.com/tadast/8827699#file-countries_codes_and_coordinates-csv https://worldclim.org/data/worldclim21.html https://data.worldbank.org/indicator https://apps.who.int/nha/database/